The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Over the last few decades, we have seen incredible innovation in different types of therapeutic modalities. Cell and Gene therapies encompass many diverse approaches. Added to that are Live Biological Products (Microbiome) and increasingly complex combination approaches…
How does standardization of aseptic filling accelerate drug development? Traditionally aseptic filling processes were developed as a custom solution late in the drug development process, often dedicated to a single drug candidate…
As the advanced therapies landscape continues to evolve, with the ever increasing number of new cell and gene therapy products being evaluated along with anticipated regulatory approvals on the rise, how can we enhance delivery of these transformational treatments to patients? Cynthia will discuss…
Key challenges in pDNA manufacturing exist around purification unit operations due to its large size, high viscosity, shear sensitivity, and similarities between pDNA and impurities…